FDC Limited Share Price

FDC Limited Share Price

NSE: FDC
|
Pharmaceuticals
|
S Cap
₹ 358.75
+₹5.00 (1.41%)
1D
Last updated 13 Aug, 2026, 15:59 IST

FDC Limited Share Price Today

As of 14 Aug 2026, FDC Limited share price is ₹358.75. The stock opened at ₹354.70, compared to its previous close of ₹353.75. During today's trading session, FDC Limited share price moved in the range of ₹351.05 to ₹364.35, with an average price of ₹357.70 for the day. Looking at its last 52-week, the stock has touched a low of ₹312.95 and a high of ₹527.80. On the performance front, FDC Limited share price has declined by 4.66% over the last six months and is down 25.76% on a year-on-year basis.


₹351.05
1.41% up today
₹364.35
1D LOW
1D HIGH

FDC Limited Returns Calculator


Circuit
L
H
₹283.00
₹424.50
52-week
L
H
₹312.95
₹527.80

About FDC Limited

FDC Limited Share Price
ISIN
INE258B01022
Sector Market Cap
₹ 5,837.56 Cr

FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.

FDC Limited Financial Highlights

  • Revenue: FDC Limited reported revenue of ₹2,284.45 crore in FY26 vs ₹2,198.78 crore in FY25. It showed an increase of 3.90% on a yearly basis.
  • Operating Profit: FDC Limited reported an operating profit of ₹374.60 crore in FY26 vs ₹357.22 crore in FY25. It showed an increase of 4.87% on a year-on-year basis.
  • Net Profit: FDC Limited reported a net profit of ₹281.42 crore in FY26 vs ₹266.79 crore in FY25. It showed an increase of 5.48% on a yearly basis.

FDC Limited Quarterly Result Highlights

  • FDC Limited reported revenue of ₹715.35 crore in Jun 2026, compared with ₹634.68 crore in Mar 2026, representing an increase of 12.71% on a quarter-on-quarter (QoQ) basis.
  • FDC Limited reported an operating profit of ₹174.70 crore in Jun 2026, compared with ₹140.36 crore in Mar 2026, representing an increase of 24.47% on a quarter-on-quarter (QoQ) basis.
  • FDC Limited reported a profit of ₹132.49 crore in Jun 2026, compared with ₹103.40 crore in Mar 2026, reflecting an increase of 28.13% on a QoQ basis.
  • The earnings per share (EPS) of FDC Limited stood at ₹16.39 during Jun 2026.
Know more
Promoters
69.66%
FII
1.40%
Other DII
0.06%
Retail and other
22.63%
Mutual funds
6.25%
Foreign institutions - FII
FII shareholding by period
Sep 20252.43%
Dec 20252.32%
Mar 20262.40%
Jun 20261.40%
Mkt Cap Cr
5,837.56

P/E
19.95

P/B
2.35

ROE
11.32%

D/E
0.01

ROCE
15.18%

Div. Yield
1.39%

EPS(TTM)
17.56
Turnover
0.73

EV/EBITDA
12.62

Net Margin
0.00%

Op. Margin
0.00%

ROA
10.02%

Quick Ratio
0.00

Curr. Ratio
3.18
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
FDC has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
FDC appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
FDC revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,64,271.0038.325.5613.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,26,843.0077.5513.5315.32%0.0019.56%629.490.35%0.5598.19
Torrent Pharmaceuticals1,86,000.0086.2722.1225.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,20,099.0026.154.4318.59%0.3117.35%237.300.08%0.3335.38
Cipla1,18,027.0035.183.4311.27%0.0014.95%423.360.89%0.4543.52
Lupin1,03,549.0018.624.6123.76%0.0424.88%659.050.79%0.57129.18
Mankind Pharma1,00,137.0048.436.1411.74%0.3413.13%397.020.04%0.4449.37
Dr. Reddy's Laboratories1,00,073.0031.442.6311.07%0.1812.54%377.960.67%0.4138.68
Laurus Labs99,474.2091.2318.7716.77%0.4016.14%97.200.11%0.6713.72
Aurobindo Pharma96,700.6026.062.559.25%0.1911.76%391.140.24%0.3841.58

FDC Limited Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹2,108.12₹1,942.94₹1,783.75₹1,527.92
Other Income₹90.66₹101.63₹49.86₹76.09
Total Revenue₹2,198.78₹2,044.58₹1,833.61₹1,604.01
Total Expenses₹1,841.56₹1,648.36₹1,575.80₹1,314.62
Profit Before Tax₹357.22₹396.22₹257.80₹289.39
Tax₹90.43₹91.16₹63.98₹73.23
Profit After Tax₹266.79₹305.06₹193.83₹216.16
EPS - Basic₹16.39₹18.58₹11.66₹12.81
EPS - Diluted₹16.39₹18.58₹11.66₹12.81

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹357.22₹396.22₹257.80₹289.39
Income before WC changes₹332.44₹345.04₹262.12₹262.91
Change in Assets₹40.70-₹39.06-₹86.03-₹91.71
Change in Liabilities₹47.23₹18.71₹56.13₹69.98
Change in WC₹87.94-₹20.35-₹29.91-₹21.72
Cash flow from Operations₹317.57₹220.77₹154.91₹161.65
Cash flow from Investing-₹199.51-₹17.08₹11.13-₹144.57
Cash flow from Financing-₹92.12-₹202.16-₹179.95-₹9.84
Total Cash Flow₹25.94₹1.53-₹13.90₹7.25
Cash (Start of the year)₹25.42₹23.89₹37.73₹30.43
Cash (End of the year)₹51.47₹25.42₹23.89₹37.73

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹1,625.09₹1,401.60₹1,317.88₹1,270.02
Current Assets₹1,088.72₹1,066.49₹1,025.06₹1,000.19
Total Assets₹2,713.80₹2,468.09₹2,342.94₹2,270.20
Current Liabilities₹361.64₹310.62₹311.56₹272.16
Net Current Asset₹727.08₹755.87₹713.50₹728.03
Non-Current Liabilities₹71.08₹60.30₹49.98₹41.69
Equity Capital₹2,281.08₹2,097.17₹1,981.40₹1,956.36
Total Equity & Liabilities₹2,713.80₹2,468.09₹2,342.94₹2,270.20

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹2,070.11₹1,916.19₹1,777.03₹1,518.97
Other Income₹105.52₹103.22₹53.91₹78.73
Total Revenue₹2,175.63₹2,019.40₹1,830.94₹1,597.70
Total Expenses₹1,807.96₹1,621.46₹1,565.25₹1,312.25
Profit Before Tax₹367.67₹397.95₹265.69₹285.45
Tax₹94.05₹90.78₹64.72₹65.82
Profit After Tax₹273.63₹307.16₹200.97₹219.64
EPS - Basic₹16.81₹18.70₹12.09₹13.01
EPS - Diluted₹16.81₹18.70₹12.09₹13.01

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹367.67₹397.95₹265.69₹285.45
Income before WC changes₹327.76₹345.62₹266.69₹261.86
Change in Assets₹42.19-₹38.27-₹81.61-₹91.21
Change in Liabilities₹43.21₹16.36₹56.50₹70.04
Change in WC₹85.40-₹21.91-₹25.11-₹21.17
Cash flow from Operations₹310.34₹220.81₹164.72₹162.38
Cash flow from Investing-₹199.45-₹17.76₹3.62-₹147.42
Cash flow from Financing-₹92.10-₹202.03-₹179.83-₹9.70
Total Cash Flow₹18.79₹1.02-₹11.49₹5.26
Cash (Start of the year)₹20.77₹19.75₹31.13₹25.72
Cash (End of the year)₹39.67₹20.77₹19.75₹31.13

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹1,642.26₹1,404.06₹1,311.66₹1,265.67
Current Assets₹1,068.06₹1,054.57₹1,023.76₹988.58
Total Assets₹2,710.32₹2,458.63₹2,335.42₹2,254.25
Current Liabilities₹355.01₹307.67₹310.69₹270.62
Net Current Asset₹713.05₹746.90₹713.07₹717.96
Non-Current Liabilities₹68.12₹53.76₹43.99₹34.94
Equity Capital₹2,287.19₹2,097.20₹1,980.74₹1,948.69
Total Equity & Liabilities₹2,710.32₹2,458.63₹2,335.42₹2,254.25
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
358.75
25
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 25
Buy orders: 0%
Sell orders: 100%
Bearish
3
Neutral
1
Bullish
4
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
24.18
Bearish

ATR (14)
14.64
Neutral

STOCH(9,6)
3.71
Bullish

STOCH RSI (14)
0
Bullish

ADX(9)
37.89
Bearish

UO(9)
28.67
Bullish

ROC(12)
-15.19
Bearish

WillR(14)
-96.29
Bullish
Period
Simple value
Exponential vaue

5D
360.71
362.98

10D
377.82
374.09

20D
395.01
387.81

50D
402.9
395.3

100D
382.12
391.77
Volume trend — traded volume by day
13 Aug1L
12 Aug1L
11 Aug2L
10 Aug2L
7 Aug2L
Average2L
Compare against other stocks
FDC Limited Share Price
FDC Limited
Pharmaceuticals
Add Stock
Add Another

FDC Limited Share Price FAQs